LifeMine Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
LifeMine Therapeutics is a clinical-stage biotechnology company pursuing Top-Down Drug Discovery, using evolutionary insights from fungi to identify precision medicines. Its data-immersive platform integrates human genetics and genomics, bioinformatics, machine learning, and synthetic biology to support discovery. The company's lead program, LIFE-001, is a novel, precision-engineered, long-acting calcineurin inhibitor being developed for multiple immunologic disorders and organ transplantation. LifeMine is headquartered in Cambridge, Massachusetts, at 30 Acorn Park Drive, 6th Floor, and employs between 11 and 50 people. The organization operates within the biotechnology research sector and engages in clinical development.